China Pharma Holdings Stock Price Prediction
| CPHI Stock | USD 0.19 0.01 5.00% |
Oversold Vs Overbought
36
Oversold | Overbought |
Wall Street Target Price 3 | Quarterly Revenue Growth (0.16) |
Using China Pharma hype-based prediction, you can estimate the value of China Pharma Holdings from the perspective of China Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in China Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying China because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
China Pharma after-hype prediction price | USD 0.19 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
China |
China Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of China Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in China Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of China Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
China Pharma Estimiated After-Hype Price Volatility
In the context of predicting China Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on China Pharma's historical news coverage. China Pharma's after-hype downside and upside margins for the prediction period are 0.01 and 7.20, respectively. We have considered China Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
China Pharma is out of control at this time. Analysis and calculation of next after-hype price of China Pharma Holdings is based on 3 months time horizon.
China Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as China Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading China Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with China Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.08 | 7.01 | 0.00 | 0.00 | 7 Events / Month | 7 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.19 | 0.19 | 0.00 |
|
China Pharma Hype Timeline
China Pharma Holdings is currently traded for 0.19. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. China is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.08%. %. The volatility of related hype on China Pharma is about 13881.19%, with the expected price after the next announcement by competition of 0.19. About 51.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.66. Some equities with similar Price to Book (P/B) outperform the market in the long run. China Pharma Holdings recorded a loss per share of 0.69. The entity had not issued any dividends in recent years. The firm had 1:5 split on the 6th of March 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days. Check out China Pharma Basic Forecasting Models to cross-verify your projections.China Pharma Related Hype Analysis
Having access to credible news sources related to China Pharma's direct competition is more important than ever and may enhance your ability to predict China Pharma's future price movements. Getting to know how China Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how China Pharma may potentially react to the hype associated with one of its peers.
China Pharma Additional Predictive Modules
Most predictive techniques to examine China price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for China using various technical indicators. When you analyze China charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About China Pharma Predictive Indicators
The successful prediction of China Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as China Pharma Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of China Pharma based on analysis of China Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to China Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to China Pharma's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.002105 | 0.00187 | Price To Sales Ratio | 0.29 | 0.28 |
Story Coverage note for China Pharma
The number of cover stories for China Pharma depends on current market conditions and China Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that China Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about China Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
China Pharma Short Properties
China Pharma's future price predictability will typically decrease when China Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of China Pharma Holdings often depends not only on the future outlook of the potential China Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. China Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.4 M | |
| Cash And Short Term Investments | 1.5 M |
Complementary Tools for China Stock analysis
When running China Pharma's price analysis, check to measure China Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Pharma is operating at the current time. Most of China Pharma's value examination focuses on studying past and present price action to predict the probability of China Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Pharma's price. Additionally, you may evaluate how the addition of China Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |